Kaitlyn Tsuruda

17PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsObstetrics and gynaecologyBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 14, 2026
Validating clinical assumptions for characterizing prostate cancer aggressiveness utilizing historical cancer registry data.

Kaitlyn M Tsuruda, Hilde Langseth, Lauren M Hurwitz

|Apr 29, 2025
Let's talk about sex: Survival among females and males in a real-world cohort treated with pembrolizumab for non-small cell lung cancer.

Kaitlyn M Tsuruda, Helga H Hektoen, Christina Aamelfot

|Feb 17, 2025
Immortal time bias in survival outcomes when comparing treatment with chemotherapy versus immunochemotherapy for non-small cell lung cancer.

Kaitlyn M Tsuruda, Helga H Hektoen, Denise Reis Costa

|Dec 18, 2024
From trials to practice: Immune checkpoint inhibitor therapy for melanoma patients in Norway.

Denise Reis Costa, Anna K Winge-Main, Anna Skog

|Nov 03, 2024
Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort study.

Helga H Hektoen, Kaitlyn M Tsuruda, Lars Fjellbirkeland

|Oct 23, 2024
Validity of self-reported number of pregnancies and maternal age at first birth among females attending organized mammographic screening.

Kaitlyn M Tsuruda, Hilde Langseth, Giske Ursin

Pageof 3

Frequent Collaborators

8 joint publications

Solveig Hofvind

3 joint publications

Trude Eid Robsahm

3 joint publications

Helga H Hektoen

3 joint publications

Bettina Kulle Andreassen